CHD9 anticorps

N° du produit ABIN5697322

Détail du produit anti-CHD9 anticorps

Antigène: CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHD9 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Immunogène: chromodomain helicase DNA binding protein 9

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

human brain tissue were subjected to SDS PAGE followed by western blot with FNab01645(CHD9 antibody) at dilution of 1:300

Restrictions: For Research Use only

Stockage

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol  pH 7.3

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze / thaw cycles.

Stock: -20 °C

Date de péremption: 12 months

Détails sur CHD9

Antigène: CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))

Autre désignation: CHD9 (CHD9 Produits)

Synonymes: anticorps CReMM, anticorps ad013, anticorps cremm, anticorps kish2, anticorps pric320, anticorps AD013, anticorps KISH2, anticorps PRIC320, anticorps 1810014J18Rik, anticorps 9030205D12Rik, anticorps A330063D19Rik, anticorps mKIAA0308, anticorps chromodomain helicase DNA binding protein 9, anticorps Chd9, anticorps CHD9, anticorps chd9

Sujet: Synonyms:KIAA0308, KISH2, PRIC320 Background:Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis(By similarity).

Poids moléculaire: 330 kDa

ID gène: 80205

UniProt: Q3L8U1

Pathways: Regulation of Lipid Metabolism by PPARalpha